Sabin Dhakal

Sabin Dhakal, PhD, currently serves as a Principal Scientist in Cancer Biology at Sonata Therapeutics, specializing in developing innovative anti-cancer therapies that leverage immune system synergy. Previous roles include Entrepreneurial Fellow at Celdara Medical, conducting due diligence on biological and pharmaceutical assets, and a Postdoctoral Fellow at Harvard Medical School, where research focused on intratumoral heterogeneity and its effects on tumor progression. Sabin's background includes a comprehensive education in biological sciences, with a PhD from Harvard University in Cancer Biology, and experience in leadership and mentorship through various programs at prestigious institutions, such as the Harvard Graduate Business Club and the Science Diplomacy Center at Tufts University.